Memic Innovative Surgery entered into an agreement to merge with blank check company MedTech Acquisition Corp. (Nasdaq: MTAC) in a deal that values the combined firms at about $1 billion.
The company, headquartered in Israel and Fort Lauderdale, is the maker of the first U.S. Food and Drug Administration-approved surgical robot that features humanoid-shaped arms, and shoulder, elbow and wrist joints that operate with human-like dexterity and 360-degree articulation. Called the Hominis platform, the device is authorized to perform transvaginal gynecological procedures, including hysterectomy for benign conditions.
